AbCellera Biologics Inc. (ABCL)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

2.80

-0.18%

After-hours Dec 13, 2024, 07:55 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	38.02M	485.42M	375.20M	233.16M	11.61M	8.83M
Cost of Revenue	-	66.44M	45.52M	27.14M	10.11M	5.80M
Gross Profit	38.02M	418.99M	329.69M	206.01M	1.50M	3.03M
Operating Income	-237.21M	216.51M	204.41M	156.03M	-4.12M	-753.00K
Interest Income	42.25M	16.08M	3.33M	293.00K	154.96K	42.00K
Pretax Income	-174.03M	239.10M	219.15M	157.83M	-2.21M	309.00K
Net Income	-146.40M	158.52M	153.46M	118.92M	-2.42M	309.00K
Selling & General & Admin	75.18M	66.75M	48.76M	15.75M	4.01M	2.86M
Research & Development	175.66M	107.88M	62.06M	29.39M	10.11M	5.80M
Other Expenses	24.39M	17.29M	-3.04M	-3.48M	-170.41K	-675.51K
Operating Expenses	275.23M	191.92M	107.79M	41.66M	13.95M	7.99M
Interest Expense	-	4.04M	5.22M	6.51M	209.20K	212.00K
Selling & Marketing Expenses	14.18M	11.27M	6.91M	3.84M	1.26M	712.00K
Cost & Expenses	275.23M	258.36M	153.30M	68.80M	13.95M	7.99M
Income Tax	-27.63M	80.58M	65.69M	38.91M	209.20K	1.27M
Shares Outstanding (Basic)	289.17M	285.06M	275.76M	269.50M	154.09M	237.72M
Shares Outstanding (Diluted)	289.17M	314.83M	318.29M	269.50M	154.09M	237.72M
EPS (Basic)	-0.51	0.56	0.56	0.44	-0.02	0.00
EPS (Diluted)	-0.51	0.50	0.48	0.44	-0.02	0.00
EBITDA	-192.16M	272.20M	241.62M	169.62M	-397.42K	165.00K
Depreciation & Amortization	30.89M	33.10M	17.25M	5.27M	1.60M	918.46K